3 days ago
Scientists tout potential weight loss advance using gene technology
There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain microproteins that store fat.
In findings published in the Proceedings of the National Academy of Sciences (PNAS) in the US, the team from the California-based Salk Institute for Biological Studies said that the microproteins "could potentially serve as drug targets to treat obesity and other metabolic disorders."
The findings could prove particularly useful for people who struggle with other treatments such as lifestyle changes, bariatric surgery or courses of drugs such as Ozempic and Wegovy.
"The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide," the Salk Institute warned, reminding that being overweight is linked to "other metabolic disorders" such as diabetes, cardiovascular diseases, chronic kidney disease, and cancers.
Microproteins, according to the team, are "an understudied class of molecules found throughout the body that play roles in both health and disease."
The team believes the findings are noteworthy because they entailed the use of CRISPR gene editing to screen thousands of fat cell genes to try to find genes "that likely code for microproteins that regulate either fat cell proliferation or lipid accumulation."
"We wanted to know if there was anything we had been missing in all these years of research into the body's metabolic processes," says Salk's Victor Pai.
Solve the daily Crossword
